FindTrial
Sign In

Effect of Botolinium injection on symptoms reduction in patients with Temporomandibular Disorders

Evaluation of Botolinium injection on symptoms reduction in patients with Temporomandibular Disorders

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130710013938N4
Enrollment
60
Registered
2018-04-09
Start date
2018-02-28
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Disorder. Temporomandibular joint disorders

Interventions

Intervention group: Patients with Temporomandibular Disorder undergo total of 50 units of botulinum Dysport toxin injection at the trigger point in the masseter muscle.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with temporomandibular disorders whom were under conservative treatment for 3 months

Exclusion criteria

Exclusion criteria: Patients have been undergone surgical procedures or have history of previous injection of botulinum toxin

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 1 week, 1 month, 3 months and 6 months after injection. Method of measurement: Visual Analogue Scale for pain.;Temporomandibular joints click sound. Timepoint: 1 week, 1 month, 3 months and 6 months after injection. Method of measurement: palpation.;Maximum jaw opening. Timepoint: 1 week, 1 month, 3 months and 6 months after injection. Method of measurement: ruler with accuracy up to one millimeter.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Ali Ghavimi

Tabriz University of Medical Sciences

Ghavimim@tbzmed.ac.ir+98 41 3335 5965

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026